Page last updated: 2024-10-21

ethylisopropylamiloride and Cardiomyopathies

ethylisopropylamiloride has been researched along with Cardiomyopathies in 1 studies

ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gambassi, G1
Carbonin, P1
Capogrossi, MC1

Other Studies

1 other study available for ethylisopropylamiloride and Cardiomyopathies

ArticleYear
[The arrhythmogenicity of alpha 1-adrenergic stimulation following myocardial acidosis].
    Cardiologia (Rome, Italy), 1992, Volume: 37, Issue:8

    Topics: Acidosis; Amiloride; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzopyrans; Cardiomyopa

1992